23.06.2015 • News

IPO Lifts Univar Free Float to 45%

Univar, the leading chemical distributor in the US and second-largest in Europe, began trading on the New York Stock Exchange on June 18 after an increased initial public offering generated $770 million in proceeds.

Private equity group CVC Capital Partners, which bought into the company in 2007, contributed 15 million shares to the 35 million placed with new owners at $22 apiece. The other private equity owner, Clayton Dubilier & Rice, which took a 42.5% stake in 2010, did not participate in the ipo.

Following the listing, which included 75% more shares than initially foreseen, the companies together own 55%. The remainder is in free float.
The over-allotment also increased in size to 5.25 million shares from the three million shares.

Simultaneously, Univar executed a private placement of $500 million with Singapore state-owned asset manager Temasek Holdings.
The distributor based near Chicago said it would use the proceeds of the stock launch to pay down debt of more than $650 million as well as making a payment to its private equity owners totaling $26 million.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.